IDO1 is the first rate-limiting enzyme in tryptophan catabolism, which can induce apoptosis or dysfunction of T cells and NK cells by mediating the depletion of tryptophan and the accumulation of its metabolite kynurenine, thus weakening the body's anti-tumor immunity [35,36]. Here, IDO1 is linked to neoplasm.